Tag: OTOFGT
Sensorion submits UK clinical trial authorization application for OTOF-GT, its most advanced gene therapy product
By Claude Leguilloux Published on 07/10/2023 at 07:46 (Boursier.com) — Sensorion a pioneering clinical-stage biotechnology company dedicated…
Sensorion submits UK clinical trial authorization application for OTOF-GT – 2023-07-10 08:38
(AOF) – Sensorion, a pioneering clinical-stage biotechnology company dedicated to developing innovative therapies to restore, treat and prevent hearing loss, announces that it has submitted an initial Clinical Trial Authorization…
Sensorion: trial request for OTOF-GT in the UK – 07/10/2023 at 08:48
(CercleFinance.com) – Sensorion announces that it has submitted a first Clinical Trial Authorization Application (CTA) for OTOF-GT to the MHRA, the UK Medicines Regulatory Agency, following extensive preclinical studies and…
Sensorion: trial request for OTOF-GT in the UK
(CercleFinance.com) – Sensorion announces that it has submitted a first Clinical Trial Authorization Application (CTA) for OTOF-GT to the MHRA, the UK Medicines Regulatory Agency, following extensive preclinical studies and…
Sensorion: Trial request for OTOF-GT in the UK
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
Sensorion submits UK clinical trial authorization application for OTOF-GT, its most advanced gene therapy product – 7/10/2023 at 07:30
Sensorion submits an application for clinical trial authorization, in the UK, for OTOF-GT, its most advanced gene therapy product. Montpellier, July 10, 2023 at 7:30 a.m. CET – Sensorion (FR0012596468…